Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1830 GMT/2:30 PM ET

Tue, 24th Apr 2018 19:40

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Wall St sunk by corporate cost warnings, bond nerves

U.S. stocks drop sharply as concerns over marquee companieswarning of higher costs were exacerbated by the benchmark U.S.10-year Treasury yield piercing the 3 percent level for thefirst time in four years. (USA-STOCKS/ (UPDATE 4), updatedthroughout the day, 430 words)

U.S. 10-year yield hits 3 pct as economy shows resilience

The U.S. benchmark 10-year Treasury yield tops 3 percent forthe first time in more than four years, a milestone thatreflects the durability of the U.S. economic expansion andstokes the view the three-decade-old bull market in bonds isnumbered. (USA-BONDS/ (UPDATE 2, TABLE, GRAPHICS), moved, byRichard Leong, 540 words)

FOCUS-Express Scripts targets Amgen, Lilly migraine drugs inpricing shift

LOS ANGELES - Express Scripts, the largest U.S. manager ofprescription benefits, is telling drugmakers that the currentpricing model is broken, and taking aim at Amgen Inc, Eli Lillyand Co and other makers of new migraine medicines to try and fixit. (HEALTH-EXPRESSSCRIPTS/AMGEN (UPDATE 1, FOCUS, PIX), moved,by Deena Beasley, 920 words)

Google-owner Alphabet's shares tumble on rise in costs

Shares of Google parent Alphabet Inc fall more than 5percent as a surge in costs drove what analysts said was itsbiggest ever contraction in gross margins, overshadowing strongfirst-quarter ad sales. (ALPHABET-RESULTS/RESEARCH (UPDATE 1),moved, by Arjun Panchadar, 430 words)

Caterpillar shares plunge on concerns earnings have peaked

CHICAGO - Caterpillar Inc's shares tumble on concerns thatrising material costs following U.S. President Donald Trump'scrackdown on steel imports would hurt its earnings in the comingquarters. (CATERPILLAR-RESULTS/ (UPDATE 4), moved, by RajeshKumar Singh, 500 words)

MARKETS

Oil slips as Trump and France's Macron talk Iran deal

NEW YORK - Oil prices slip as concerns over the possibilitythat the U.S. might reinstate sanctions against Iran fadesomewhat, alleviating worries about the future of Iranianexports. (GLOBAL-OIL/ (UPDATE 8, PIX), updated throughout theday, 430 words)

+ See also:

- OIL-PRICES/KEMP (COLUMN), moved, by John Kemp, 960 words

Bitcoin climbs to six-week high as market sentiment improves

NEW YORK - Bitcoin rises to more than $9,300, a six-weekhigh, on positive headlines that include the possible entry ofmajor financial institutions into the space, lifting sentimenton the overall cryptocurrency market.(CRYPTO-CURRENCIES/BITCOIN, moved, by Gertrude Chavez-Dreyfuss,420 words)

ECONOMY

U.S. consumer confidence rebounds; new home sales rise

WASHINGTON - U.S. consumer confidence rebounded in April andnew home sales increased more than expected in March, pointingto underlying strength in the economy despite signs that growthslowed in the first quarter. (USA-ECONOMY/ (WRAPUP 2, PIX), byLucia Mutikani, moved, 770 words)

TRADE

Trump says new NAFTA deal could be completed quickly

WASHINGTON - U.S. President Donald Trump says a new NAFTAtrade deal could be completed quickly, as ministers from Canada,Mexico and the United States prepared to meet later in the dayto try to work out their differences and hash out anagreement.(TRADE-NAFTA/ (UPDATE 2), moved, by Jeff Mason andDavid Lawder, 490 words)

COMPANIES

Shire receives new bid from Takeda as takeover deadlinelooms

LONDON - Takeda Pharmaceutical raises its $62 billion bidfor Shire as it races to agree to terms with the Britishdrugmaker before a deadline to strike a deal expires.(SHIRE-M&A/TAKEDA PHARMA (UPDATE 2), moved, by Ben Martin, 540words)

Lockheed Martin cash flow outlook disappoints, shares fall

Lockheed Martin Corp, the Pentagon's No. 1 weapons supplier,does not raise its 2018 cash flow projections even as the U.S.government spends more on defense, disappointing investors andpushing its shares lower. (LOCKHEED-RESULTS/ (UPDATE 4), moved,by Mike Stone and Rachit Vats, 570 words)

In Des Moines, Wells Fargo looks to soothe critics

Wells Fargo & Co kicks off an annual meeting in Des Moines,Iowa, where investors will likely press executives forassurances that a sweeping sales scandal is a thing of the past.(WELLS FARGO-SHAREHOLDER/MEETING (PIX), moved, by Ross Kerber,540 words)

Facebook releases long-secret rules on how it polices theservice

MENLO PARK - Facebook Inc releases a rule book for the typesof posts it allows on its social network, giving far more detailthan ever before on what is permitted on subjects ranging fromdrug use and sex work to bullying, hate speech and incitingviolence. (FACEBOOK-ABUSE/ (PIX), moved, by David Ingram, 840words)

Verizon first-quarter results beat estimates

Verizon Communications Inc, the No. 1 U.S. wireless carrier,reports higher-than-expected first-quarter revenue and thecompany's chief financial officer said it was continuing toexplore a new video service. (VERIZON-RESULTS/ (UPDATE 2),moved, by Shariq Khan and Sheila Dang, 410 words)

Coke warns of pain from UK sugar tax, U.S. freight costs

Coca-Cola Co will take a hit in the second quarter from theintroduction of a British sugar tax on soft drinks and risingfreight costs in the United States, overshadowing modestlybetter-than-forecast results for the first three months of 2018.(COCA-COLA-RESULTS/ (UPDATE 3), moved, by Nivedita Balu andSiddharth Cavale, 390 words)

Harley-Davidson backs forecast, investors see signs ofrecovery

Harley-Davidson Inc stands by its full-year motorcycleshipments forecast and says it expects dealers to sell moremotorcycles in overseas markets, offering a glimmer of hope to abusiness struggling with an aging customer base in the UnitedStates. (HARLEY DAVIDSON-RESULTS/ (UPDATE 3), moved, by ArunimaBanerjee, 400 words)

United Airlines CEO forgoes 2017 bonus, board chairman tostep down

NEW YORK - United Airlines' chief executive decided to dowithout his 2017 annual bonus and the carrier's board chairmanwill step down, United says in a regulatory filing, amid ongoingfallout surrounding its customer-service failures.(UAL-EXECUTIVES/, moved, by Alana Wise, 380 words)

To beat porch thieves, Amazon slips packages in car trunks

Not content to stop at slipping packages inside customers'front doors, Amazon.com Inc starts a new program to deliverpackages to its members' parked cars. (AMAZON.COM-AUTOS/ (UPDATE1, PIX, TV), moved, by Stephen Nellis, 510 words)

ALSO IN THE NEWS

China-bound U.S. sorghum diverted to Saudi Arabia, Japan

DUBAI/CHICAGO - Four U.S. sorghum shipments initially boundfor China have been diverted to other countries followingBeijing's move last week to impose hefty anti-dumping depositson imports of the grain from the United States, according totrade sources and Reuters shipping data. (US-SORGHUM/SHIP(UPDATE 3), moved, by Maha El Dahan and Karl Plume, 400 words)

Inside Deripaska's scramble to soften Russia sanctions blow

MOSCOW/LONDON - In December, as news reports emerged aboutpotential new U.S. sanctions against Russia, aluminum magnateOleg Deripaska instructed advisers to draw up contingency plans,according to people close to the businessman and his companies.(USA-RUSSIA/SANCTIONS-DERIPASKA (REPEAT, INSIGHT), moved, byPolina Devitt, Dmitry Zhdannikov and Julia Payne, 1,270 words)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.